review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034609797 |
P356 | DOI | 10.1007/BF00308627 |
P698 | PubMed publication ID | 7754624 |
P2093 | author name string | J A Roth | |
P2860 | cites work | Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma | Q33475958 |
Frequent mutation of the p53 gene in human esophageal cancer | Q33927516 | ||
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction | Q37527489 | ||
Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. | Q38488555 | ||
p53 gene mutations in Barrett's epithelium and esophageal cancer | Q38488725 | ||
Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma | Q38490224 | ||
Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction | Q39533291 | ||
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction | Q41188853 | ||
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. | Q41657557 | ||
Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus | Q44680632 | ||
Autopsy findings in squamous-cell carcinoma of the esophagus | Q46550086 | ||
Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus | Q47349982 | ||
Adenocarcinoma of the esophagus: relationship to Barrett mucosa | Q47607226 | ||
The genetic origin of drug resistance in neoplasms: implications for systemic therapy. | Q52688528 | ||
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations | Q53497225 | ||
Cis-diamminedichloride platinum(II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study. | Q54541788 | ||
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. | Q54607288 | ||
Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis. | Q55153791 | ||
p53 Gene Mutations in Esophageal Cancer Detected by Polymerase Chain Reaction Single-strand Conformation Polymorphism Analysis | Q55383452 | ||
Autopsy Findings in Carcinoma of the Esophagus | Q66951988 | ||
Resection and reconstruction for carcinoma of the thoracic oesophagus | Q67442999 | ||
A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapy | Q67837183 | ||
Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas | Q67898347 | ||
p53 gene mutations in gastric and esophageal cancers | Q68011829 | ||
Rising incidence of adenocarcinoma of the esophagus and gastric cardia | Q68199481 | ||
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma | Q68317206 | ||
Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital | Q68762155 | ||
Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposition | Q68811899 | ||
Management of esophageal cancer | Q68827294 | ||
Carcinoma of the esophagus: treatment results | Q68961758 | ||
Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037) | Q68965886 | ||
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus | Q69033494 | ||
The results of esophagogastrectomy without thoracotomy for adenocarcinoma of the esophagogastric junction | Q69107411 | ||
Comparison of three treatment strategies for esophageal cancer within a single institution | Q69424368 | ||
Improved survival in esophageal cancer in the period 1978 to 1983 | Q69550954 | ||
Barrett's esophagus | Q69885120 | ||
Adenocarcinoma of the distal esophagus and gastric cardia. Comparison of results of transhiatal esophagectomy and thoracoabdominal esophagogastrectomy | Q70006323 | ||
Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus | Q70579961 | ||
Adenocarcinoma and Barrett's esophagus. An overrated risk? | Q70587541 | ||
Esophageal cancer. Autopsy findings in 171 cases | Q70817324 | ||
Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy | Q70980632 | ||
En bloc resection for neoplasms of the esophagus and cardia | Q71728945 | ||
Combined modality therapy of esophageal carcinoma | Q72635989 | ||
Treatment of Esophageal Carcinoma by Combined Preoperative Chemotherapy | Q72680672 | ||
The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third | Q82160638 | ||
P433 | issue | 2 | |
P921 | main subject | Multimodal cancer therapy | Q108855235 |
P304 | page(s) | 205-209 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | World Journal of Surgery | Q15763279 |
P1476 | title | Multimodality treatment of cancer arising from Barrett's epithelium | |
P478 | volume | 19 |
Search more.